128 results
Page 2 of 7
8-K
EX-10.1
s49t8
23 Nov 22
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-10.2
i39tb
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.1
slmjcg
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.1
4jsg svgwrxp
20 Jul 22
Entry into a Material Definitive Agreement
7:01pm
8-K
EX-10.1
ctc 4xqggl
17 Jun 22
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-10.1
cur xizkhca
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.2
faf vjj966luj4
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
c9youz
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.2
cbz3i4a9uqke47x
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.1
ff5 v495z17qw4euvjr2
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
xvcx4aiakfrr49h rxg5
6 Oct 21
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
12:00am
8-K
EX-10.1
bgumpamxz18fft
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am